Profile
Richard Lewis served as the Chief Medical Officer at Aerie Pharmaceuticals, Inc. from 2015 to 2022.
Prior to that, he received his undergraduate and doctorate degrees from Chicago Medical School.
Former positions of Richard Lewis
| Companies | Position | End |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2021-12-31 |
Training of Richard Lewis
| Chicago Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Stock Market
- Insiders
- Richard Lewis
